David M. Steinberg

DAVID M. STEINBERG, Managing Director, joined Deutsche Bank in August
1999 and is currently a Senior Analyst covering the specialty
pharmaceuticals sector. Having started his equity research career in
1990, he was one of the first analysts on Wall Street to cover the
specialty pharmaceuticals/ drug delivery sector. More recently, during
both 2000 and 2001, Mr. Steinberg was ranked number two by The Wall
Street Journal’s ‘Best on the Street’ survey for stock picking in the
pharmaceutical sector. In addition, his research has been frequently
referenced in such national publications as Barron’s, The New York
Times, and Fortune. Prior to joining Deutsche Bank Securities
(previously Deutsche Banc Alex. Brown), he was a Managing Director at
Volpe, Brown, Whelan where he helped build up the firm’s healthcare
research effort. He received a BA from Colby College and an MBA from
Harvard Business School. He also attended the London School of
Economics.